| Literature DB >> 26843995 |
Tomomi Hara1, Haruhiko Kanasaki1, Aki Oride1, Tomoko Ishihara1, Satoru Kyo1.
Abstract
Acute pancreatitis is rare in pregnancy, with an estimated incidence of approximately 1 in 1000 to 1 in 10,000 pregnancies. Acute pancreatitis in pregnancy usually occurs in the third trimester. Here, we report a case of acute pancreatitis in the first trimester. A 36-year-old primigravida at 11 weeks of gestation complained of severe lower abdominal pain. The pain gradually worsened and migrated toward the epigastric region. She had no history of chronic alcoholism. Blood investigations showed elevated level of C-reactive protein (9.58 mg/dL), pancreatic amylase (170 IU/L), and lipase (332 IU/L). There was no gallstone and no abnormality in the pancreatic and biliary ducts on ultrasonography. Antinuclear antibody and IgG4 were negative and no evidence of hyperlipidemia or diabetes was found. There was also no evidence of viral infection. On the third day of hospitalization, she was diagnosed with severe acute pancreatitis on magnetic resonance imaging. Medical interventions were initiated with nafamostat mesilate and ulinastatin, and parenteral nutrition was administered through a central venous catheter. On the eighth day of hospitalization, her condition gradually improved with a decreased level of pancreatic amylase and the pain subsided. After conservative management, she did not have any recurrence during her pregnancy.Entities:
Year: 2015 PMID: 26843995 PMCID: PMC4710924 DOI: 10.1155/2015/469527
Source DB: PubMed Journal: Case Rep Obstet Gynecol ISSN: 2090-6692
Laboratory data of blood analysis on the next morning of hospitalization and additional data.
| Data on the next morning of hospitalization | |
|
| |
| WBC | 7020/ |
| RBC | 4.22 × 106/ |
| Hb | 13.1 g/dL |
| Hct | 36.70% |
| Plt | 210 × 103/ |
| Neutrophils | 85.40% |
| Eosinophils | 0.40% |
| Lymphocytes | 7.90% |
| PT% | 76.00% |
| PT-INR | 1.16 |
| APTT | 33.6 sec |
| Fibrinogen | 477 mg/dL |
| D-dimer | 11.0 |
| TP | 7.1 g/dL |
| Alb | 4.3 g/dL |
| T-Bil | 1.4 mg/dL |
| AST | 14 IU/L |
| ALT | 12 IU/L |
| BUN | 5.7 mg/dL |
| Cr | 0.37 mg/dL |
| CRP | 9.58 mg/dL |
| PCT | 0.36 ng/mL |
| Amylase | 201 U/L |
| P-amylase | 170 IU/L |
| Lipase | 332 IU/L |
| LDH | 180 U/L |
| Alp | 166 U/L |
|
| 25 U/L |
| ChE | 159 mg/dL |
| Cholesterol | 136 mg/dL |
| Triglyceride | 67 mg/dL |
| LDL cholesterol | 70 mg/dL |
| HDL cholesterol | 53 mg/dL |
| FBS | 96 mg/dL |
|
| |
| Additional data | |
|
| |
| CA19-9 | 26 U/mL |
| CEA | 1.2 ng/mL |
| ANA | >40-fold |
| IgG | 1124 mg/dL |
| IgG4 | 58 mg/mL |
| IgM | 55 mg/dL |
| IgA | 243 mg/dL |
| HBs antigen | (−) |
| HCV antibody | (−) |
| HIV antibody | (−) |
| TPHA | (−) |
| HTLV-1 | (−) |
| CMV-IgG | >4-fold |
| CMV-IgM | 0.01 C.O.I |
| RS virus antibody | >4-fold |
| Anti-adenovirus antibody | 4-fold |
| Mumps virus antibody IgG | (±) |
| Mumps virus antibody IgM | (−) |
| Anisakis larvae antibody | (−) |
| Coxsackie virus B1~B6 | >4-fold |
| Anti-rubella antibody HI | 256-fold |
| EBV-IgG | (−) |
WBC: white blood cells; RBC: red blood cells; Hb: hemoglobin; Hct: hematocrit; Plt: platelet; PT: prothrombin time; INR: international normalized ratio; APTT: activated partial thromboplastin time; TP: total protein; Alb: albumin; T-Bil: total bilirubin; AST: aspartate transaminase; ALT: alanine aminotransferase; BUN: blood urea nitrogen; Cr: creatinine; CRP: C-reactive protein; PCT: procalcitonin; LDH: lactate dehydrogenase; Alp: alkaline phosphatase; γ-GTP: γ-glutamyl transpeptidase; ChE: cholinesterase; FBS: fasting blood sugar; CA19-9: carbohydrate antigen 19-9; CEA: carcinoembryonic antigen; ANA: antinuclear antibody; TPHA: Treponemapallidum hemagglutination test; CMV: cytomegalovirus; C.O.I: cutoff index; HI: hemagglutination inhibition test; EBV: Epstein-Barr virus.
Figure 1MRI T2W. (▼) Enlargement of the pancreatic body. (→) Inflammation of acute pancreatitis, extending to fat tissue and reaching beyond the lower pole of the kidney.
Figure 2Clinography after hospitalization. Serum levels of CRP and pancreatic amylase (P-Amy) are shown. Medical interventions are shown in the graph.